JPH0892109A - Zoo/phytocrude-drug - Google Patents
Zoo/phytocrude-drugInfo
- Publication number
- JPH0892109A JPH0892109A JP25423294A JP25423294A JPH0892109A JP H0892109 A JPH0892109 A JP H0892109A JP 25423294 A JP25423294 A JP 25423294A JP 25423294 A JP25423294 A JP 25423294A JP H0892109 A JPH0892109 A JP H0892109A
- Authority
- JP
- Japan
- Prior art keywords
- powder
- drug
- effects
- phytocrude
- zoo
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Landscapes
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
【０００１】[0001]
【産業上の利用分野】本発明は動・植物生薬、より詳細
には、植物生薬と動物生薬とを混合して成り、それらの
相乗作用によって主に疲労回復、活力増進効果が得られ
る生薬に関するものである。BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to animal and plant herbal medicines, and more particularly to a herbal medicine which is a mixture of a plant crude drug and an animal crude drug, and which has a synergistic effect to mainly recover fatigue and enhance vitality. It is a thing.
【０００２】[0002]
【従来の技術】従来疲労回復、活力増進のための動物生
薬としては、スッポンやマムシがよく知られており、主
にドリンク剤として利用されている。その配合例を示せ
ば、１日服用分としてスッポン粉末１．０ｇ〜３．０ｇ
及びマムシ粉末０．５ｇ〜１．０ｇに田七人参１．０ｇ
〜３．０ｇを加えたものがある。普通の成人であれば、
この配合にて十分疲労回復、活力増進等の作用が生ずる
が、過労死に至るに近い症状を持った人（３０代後半か
ら５０代前半の６人に１人がそのような症状を持ってい
ると言われている。）の場合は、上記配合では十分な作
用が現われないため、より強い作用が得られる生薬が求
められている。2. Description of the Related Art Suppon and pit viper have been well known as animal crude drugs for recovering fatigue and promoting vitality, and are mainly used as drinks. If you show the example of the mixture, 1.0g to 3.0g of Suppon powder as a daily dose
And 0.5 g to 1.0 g of pit viper powder, 1.0 g of ginseng
Some have added ~ 3.0g. If you are a normal adult,
With this combination, the effects of recovery from fatigue, promotion of vitality, etc. occur, but people with symptoms close to death from overwork (1 in 6 people in their late 30s to early 50s have such symptoms) In this case, since the above-mentioned formulation does not show a sufficient action, a crude drug capable of obtaining a stronger action is required.
【０００３】[0003]
【発明が解決しようとする課題】然るに、上記スッポン
粉末、マムシ粉末等の配合量を増加させた場合には、副
作用又は過剰作用が現われる。即ち、スッポンやマムシ
の配合量を増加させると血圧が上昇し、また、田七人参
の配合量を増加させると食欲減退を起こすといった好ま
しくない症状が現れる。そこで本発明は、上記配合量を
変えることなくその疲労回復、活力増進といった作用を
増強でき、しかも副作用、過剰作用の心配がない動・植
物生薬を提供することを課題とする。However, when the blending amount of the above-mentioned soft-shelled turtle powder, pit viper powder, etc. is increased, a side effect or an excessive action appears. That is, increasing the blended amount of Suppon or Mamushi causes an increase in blood pressure, and increasing the blended amount of Tabuchi ginseng causes a decrease in appetite. Therefore, it is an object of the present invention to provide an animal or plant herbal medicine which can enhance the effects such as recovery from fatigue and promotion of vitality without changing the above-mentioned blending amount, and there is no fear of side effects or excessive action.
【０００４】[0004]
【課題を解決するための手段】本発明は、１日服用分と
してスッポン粉末１．０ｇ〜３．０ｇ、マムシ粉末０．
５ｇ〜１．０ｇ、田七人参１．０ｇ〜３．０ｇにキキョ
ウコン０．３ｇ〜０．７ｇ及び甘草０．３ｇ〜０．７ｇ
を配合したことを特徴とする動・植物生薬、を以て上記
課題を解決した。According to the present invention, as a daily dose, 1.0 g to 3.0 g of terrapin powder and 0.
5g-1.0g, Chinese ginseng 1.0g-3.0g, and ginger root 0.3g-0.7g and licorice 0.3g-0.7g
The above-mentioned problems were solved by using an animal or plant herbal medicine characterized by being added.
【０００５】[0005]
【作 用】消炎作用のあるキキョウコン及び消炎作用を
助長する甘草が配合されることにより細胞の炎症状態が
抑えられ、以てスッポン粉末等の他の配合成分の作用が
十分に発揮される環境が作り出される。[Working] An environment in which the inflammatory state of cells is suppressed by the inclusion of kyomoku which has an anti-inflammatory effect and licorice that promotes the anti-inflammatory effect, and the effects of other ingredients such as soft-shelled turtle powder are fully exerted. Is created.
【０００６】[0006]
【実施例】本発明に係る動・植物生薬は、１日服用分と
してスッポン粉末１．０ｇ〜３．０ｇ、マムシ粉末０．
５ｇ〜１．０ｇ、田七人参１．０ｇ〜３．０ｇにキキョ
ウコン０．３ｇ〜０．７ｇ及び甘草０．３ｇ〜０．７ｇ
を配合して成る。EXAMPLE A herb and plant herb medicine according to the present invention is a daily dose of 1.0 to 3.0 g of Suppon powder and 0.
5g-1.0g, Chinese ginseng 1.0g-3.0g, and ginger root 0.3g-0.7g and licorice 0.3g-0.7g
It is composed by blending.
【０００７】スッポン粉末、マムシ粉末及び田七人参の
配合量を上記の通りとしたのは、それよりも少ないと作
用が現われにくく、また、それよりも多いと副作用、過
剰作用を起こすという臨床上の知見に基づく。本発明で
は、スッポン粉末、マムシ粉末及び田七人参の配合量は
従来通りに抑えつつ、更に植物生薬であるキキョウコン
と甘草とをそれぞれ０．３ｇ〜０．７ｇ、好ましくは
０．５ｇ添加する。The above-mentioned amounts of terrapin powder, pit viper powder and Tachi-nin ginseng are mixed in the above amounts, and if the amount is less than that, the action is difficult to appear, and if the amount is more than that, side effects and excessive actions are caused clinically. Based on the knowledge of. In the present invention, while suppressing the compounding amounts of terrapin powder, pit viper powder and Tabana ginseng as in the conventional case, 0.3 g to 0.7 g, and preferably 0.5 g, of botanical herbs, kyokkon and licorice, are added. .
【０００８】キキョウコンには消炎作用があり、甘草に
は消炎作用を助長する作用がある。細胞に炎症があると
きは勿論、それに近い状況にあるときにも薬効が悪くな
るという事実があることが知られている。従って、消炎
作用のある成分を添加しておけば、他の配合成分の薬効
を十分に発揮させ得る状況を作り出すであろうことが理
解される。本発明においては、キキョウコン及び甘草が
その役割を果たすのである。Ginkgo biloba has an anti-inflammatory action, and licorice has an action of promoting the anti-inflammatory action. It is known that there is a fact that the drug efficacy becomes worse not only when cells have inflammation but also when they are in a situation close to that. Therefore, it is understood that the addition of a component having an anti-inflammatory effect will create a situation in which the drug effect of other compounding ingredients can be sufficiently exerted. In the present invention, Ginkgo biloba and licorice play its role.
【０００９】本発明に係る動・植物生薬を高速液体クロ
マトグラフィ−にかけ、その化学成分を分析したとこ
ろ、スッポン粉末、マムシ粉末及び田七人参だけのとき
の化学成分と何ら変わりはなかった。このことから、本
発明において添加されるキキョウコン及び甘草が、他の
スッポン粉末等の配合成分と化学的に反応せず、それら
の作用を損なうことがないことが確認され、上記スッポ
ン粉末等に添加する消炎作用のある生薬として好適なも
のであることが確認された。When the animal or plant crude drug according to the present invention was subjected to high performance liquid chromatography and the chemical components thereof were analyzed, it was no different from the chemical components of only turtle powder, pit viper powder and Tanchi ginseng. From this, it is confirmed that the ginkgo biloba and the licorice added in the present invention do not chemically react with other ingredients such as the soft-shelled turtle powder and do not impair their action. It was confirmed to be suitable as an added crude drug having an anti-inflammatory effect.
【００１０】本発明の有効性を確認するため、ひどく疲
労を訴える３０代から４０代の過労死に至り得る潜在的
患者と考えられる人５０人に、本発明に係る生薬と、キ
キョウコン及び甘草を含まない従来の生薬、並びに、キ
キョウコン及び甘草だけの生薬の３種類を、内容を教え
ることなく数回宛服用させた。その結果、５０人全員が
本発明に係る生薬の有効性を認めた。勿論その全員につ
き、副作用、過剰作用は起きていない。In order to confirm the effectiveness of the present invention, 50 people who are considered to be potential patients who may die of overwork in their thirties and forties who complain of severe fatigue are treated with the crude drug according to the present invention, and cypress and licorice. The conventional herbal medicines that did not contain it, and the three kinds of herbal medicines that were only ginseng and licorice were given several times without teaching the contents. As a result, all 50 people confirmed the effectiveness of the crude drug according to the present invention. Of course, all of them did not have any side effects or excessive effects.
【００１１】[0011]
【発明の効果】本発明は上述した通りであって、キキョ
ウコン及び甘草の消炎作用によって細胞の消炎状態が治
癒緩和され、以てスッポン、マムシ及び田七人参の配合
量を増量することなくそれらの疲労回復、活力増強等の
優れた薬効作用を十分に発揮させることができ、副作
用、過剰作用を惹起する虞がない効果がある。EFFECTS OF THE INVENTION The present invention is as described above, in which the anti-inflammatory action of Kyokyokon and licorice cures and relieves the cell's anti-inflammatory state, and thus, Suppon, Mamushi and Tabuchi ginseng are added without increasing the compounding amount thereof. The excellent medicinal effects such as recovery from fatigue and enhancement of vitality can be sufficiently exerted, and there is an effect that side effects and excessive effects are not likely to occur.
Claims (1)
〜３．０ｇ、マムシ粉末０．５ｇ〜１．０ｇ、田七人参
１．０ｇ〜３．０ｇにキキョウコン０．３ｇ〜０．７ｇ
及び甘草０．３ｇ〜０．７ｇを配合したことを特徴とす
る動・植物生薬。1. 1.0 g of soft-shelled turtle powder as a daily dose
~ 3.0g, Mamushi powder 0.5g ~ 1.0g, Chinese ginseng 1.0g ~ 3.0g, and Kyoukyokon 0.3g ~ 0.7g
And an animal or plant herbal medicine characterized by containing 0.3 to 0.7 g of licorice.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25423294A JPH0892109A (en) | 1994-09-22 | 1994-09-22 | Zoo/phytocrude-drug |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP25423294A JPH0892109A (en) | 1994-09-22 | 1994-09-22 | Zoo/phytocrude-drug |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| JPH0892109A true JPH0892109A (en) | 1996-04-09 |
Family
ID=17262105
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP25423294A Pending JPH0892109A (en) | 1994-09-22 | 1994-09-22 | Zoo/phytocrude-drug |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JPH0892109A (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09294572A (en) * | 1996-04-26 | 1997-11-18 | Toshio Yamada | Health drink |
| US8795742B2 (en) | 2006-01-20 | 2014-08-05 | Livzon Pharmaceutical Group Inc. | Chinese traditional medicine composition for treatment of avian influenza, method for preparation and application thereof |
-
1994
- 1994-09-22 JP JP25423294A patent/JPH0892109A/en active Pending
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH09294572A (en) * | 1996-04-26 | 1997-11-18 | Toshio Yamada | Health drink |
| US8795742B2 (en) | 2006-01-20 | 2014-08-05 | Livzon Pharmaceutical Group Inc. | Chinese traditional medicine composition for treatment of avian influenza, method for preparation and application thereof |
| US9265805B2 (en) | 2006-01-20 | 2016-02-23 | Livzon Pharmaceutical Group Inc. | Chinese traditional medicine composition for treatment of avian influenza, method for preparation and application thereof |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Platel et al. | Digestive stimulant action of spices: a myth or reality? | |
| Necyk et al. | Natural health products and diabetes: a practical review | |
| US5324516A (en) | Galenic composition for decreasing blood alcohol concentration | |
| CN101365465A (en) | Composition comprising liquiritigenin for preventing and treating liver disease | |
| Anthony et al. | Regulated effects of Capsicum frutescens supplemented diet (CFSD) on fasting blood glucose level, biochemical parameters and body weight in alloxan induced diabetic Wistar rats | |
| Verma et al. | Greater cardamom (Amomum subulatum Roxb.)–A cardio-adaptogen against physical stress | |
| CN107006856A (en) | One kind enhancing endurance, raising anti anoxia tolerance nutritional agents and preparation method thereof | |
| CN101869687B (en) | Medicament for treating fatty liver and alcohol liver, and reducing blood lipid and aminotransferase | |
| CN103251698A (en) | Puerarin beverage with effects of dispelling alcoholism, protecting liver and protecting stomach and preparation method thereof | |
| Zothantluanga et al. | Awareness on the possible adverse effects of Garcinia cambogia: A scientific approach | |
| JPH0892109A (en) | Zoo/phytocrude-drug | |
| Zare et al. | Reporting of adverse effects of pomegranate in clinical studies: a systematic review | |
| CN103251822B (en) | Qi-tonifying and dizziness-relieving Chinese medicine preparation for treating ischemic stroke, coronary disease and angina | |
| JPH10236966A (en) | Composition having blood circulation-ameliorating effect | |
| Suryawati et al. | The use of herbal medicines by the elderly in rural area in Indonesia: A cross-sectional study among Acehnese | |
| JP2001261569A (en) | Antiobestic agent | |
| CN103920023A (en) | Traditional Chinese medicine for treating hypertension | |
| Ahmed | Effect of Mixture of Chia, Flax and Milk thistle Seeds on Carbon Tetrachloride (CCl4) Induced Hepatotoxicity in Female Albino Rats. | |
| CN1246020C (en) | Composition for alcohol type fatty liver | |
| Fasan et al. | Evaluation of Antioxidant Potential and Efficacy of Terpenoid Rich Fraction of Phyllanthus Amarus (Schum and Thonn) Whole Plant in the Amelioration of High Salt Diet Induced Obesity. | |
| CN1205970C (en) | Toxin expelling and face nursing aloe capsule and its making process | |
| Dange et al. | Comparative Efficay Of Five Indigenous Compound Formulations In Patients Of Acute Viral Hepatitis. | |
| CN1309404C (en) | Hypertension treating medicine capable of protecting target organ and its production process | |
| CN1170578C (en) | Composite medicine for improving memory and intelligence | |
| KR20040087099A (en) | Herb-medical mixture of katzenjammer cure and digester |